Tricyclic derivatives as LTD4 antagonists
US7557212B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2003 |
| Grant date | Jul 7, 2009 |
| Priority date | — |
| Expiry date | Nov 16, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and their pharmaceutically acceptable salts are provided as well as processes for the manufacture of such compounds. The compounds are useful in the treatment or prevention of inflammatory and allergic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.